Novel Approach to the Treatment of Neuropathic Pain Using a Combination with Palmitoylethanolamide and Equisetum arvense L. in an In Vitro Study
International Journal of Molecular Sciences · 13.03.2023 · 24 (6) · 5503
DOI: 10.3390/ijms24065503 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.03.2023. Verfasst von Sara Ruga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Physiology, Department of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy. Hauptthemen laut MEDLINE: Equisetum, Neuralgia. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MUR–M4C2 1.5 of the PNNR.
Abstract (Originalsprache)
Neuropathic pain is a typical patient disorder resulting from damage and dysfunction of the peripheral neuraxis. Injury to peripheral nerves in the upper extremities can result in a lifelong reduction in quality of life and a devastating loss of sensory and motor function. Since some standard pharmaceutical therapies can cause dependence or intolerance, nonpharmacological treatments have gained great interest in recent years. In this context, the beneficial effects of a new combination of palmitoylethanolamide and Equisetum arvense L. are evaluated in the present study. The bioavailability of the combination was initially analyzed in a 3D intestinal barrier simulating oral intake to analyze its absorption/biodistribution and exclude cytotoxicity. In a further step, a 3D nerve tissue model was performed to study the biological effects of the combination during the key mechanisms leading to peripheral neuropathy. Our results demonstrate that the combination successfully crossed the intestinal barrier and reached the target site, modulating the nerve recovery mechanism after Schwann cell injury and offering the initial response of relieving pain. This work supported the efficacy of palmitoylethanolamide and Equisetum arvense L. in reducing neuropathy and modifying the major pain mechanisms, outlining a possible alternative nutraceutical approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Physiology, Department of Translational Medicine, University of Piemonte Orientale, Via Solaroli 17, 28100 Novara, Italy.
- Noivita Srls, Spin-Off, Via Alfieri 3, 28100 Novara, Italy.
- Physical and Rehabilitation Medicine, Department of Health Sciences, University of Eastern Piedmont, 28100 Novara, Italy.
- Translational Medicine, Dipartimento Attività Integrate Ricerca e Innovazione (DAIRI), Azienda Ospedaliera SS, Antonio e Biagio e Cesare Arrigo, 15121 Alessandria, Italy.
ORCID-Profile: Marco Invernizzi, Francesca Uberti
Förderung
- MUR–M4C2 1.5 of the PNNR
Zitieren
APA
Ruga, S., Galla, R., Ferrari, S., Invernizzi, M., & Uberti, F. (2023). Novel Approach to the Treatment of Neuropathic Pain Using a Combination with Palmitoylethanolamide and Equisetum arvense L. in an In Vitro Study. International Journal of Molecular Sciences, 24(6), 5503. https://doi.org/10.3390/ijms24065503
Vancouver
Ruga S, Galla R, Ferrari S, Invernizzi M, Uberti F. Novel Approach to the Treatment of Neuropathic Pain Using a Combination with Palmitoylethanolamide and Equisetum arvense L. in an In Vitro Study. International Journal of Molecular Sciences. 2023;24(6):5503. doi:10.3390/ijms24065503
BibTeX
@article{Ruga2023,
author = {Ruga, Sara and Galla, Rebecca and Ferrari, Sara and Invernizzi, Marco and Uberti, Francesca},
title = {Novel Approach to the Treatment of Neuropathic Pain Using a Combination with Palmitoylethanolamide and Equisetum arvense L. in an In Vitro Study},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {6},
pages = {5503},
doi = {10.3390/ijms24065503}
}
EUVIMED